Randomized placebo-controlled trial of canakinumab in Schnitzler syndrome

Krause K, et al.

J Allergy Clin Immunol · 2017

Grade ARCTVerified
DOI ↗PubMed ↗

Key Findings

  • ●Randomized placebo-controlled study confirming canakinumab effectiveness
  • ●Only RCT conducted in Schnitzler syndrome

Referenced in (1 disease)

Schnitzler Syndrome

Validation history

Full log →
  1. passsource metadataJun 1, 2026, 01:59 PMby pubmed-api

    Matched to a PubMed record by title + author during Issue-3 backfill; PMID and DOI resolved from PubMed E-utilities.

    tools: pubmed.esummary

ID: manual-k-2015-randomized-placebocontrolled-trialDOI: 10.1016/j.jaci.2016.07.041PMID: 27658762